Geron Corporation (GERN) - NASDAQ
Company Description
Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo... More
Sector: Healthcare
Industry: Biotechnology
Country: United States